Table 6.

Median survival months.

The whole sample (n = 2,072)
Factors	Overall	Organ metastasis	No organ metastasis	Bone metastasis	Brain metastasis	Liver metastasis	Lung metastasis
Median survival months	10	4	21	4	5	3	4

The overall median survival time of the disease was 10 months, 21 months in the non-organ metastasis group, 4 months in the organ metastasis group, 4 months in the bone metastasis and lung metastasis groups, 3 months in the liver metastasis group, and 5 months in the brain metastasis group.